City Hill Ventures
Contact Us  
Home About Us Team News

News and Events

Ignyta Receives Orphan Drug Designation and Rare Pediatric Disease Designation from FDA for Entrectinib for the Treatment of Neuroblastoma

12.29.14 press release

© 2010 City Hill Ventures, LLC Home    About Us    Team    Portfolio    News    Contact Us
Learn More